Comparing the Top Two: Autodesk, Inc. (NASDAQ:ADSK), China Pharma Holdings, Inc. (NYSE:CPHI)

Autodesk, Inc. (NASDAQ:ADSK)

Autodesk, Inc. (NASDAQ:ADSK) closed at $239.19 on the last trading session with an increase of 3.02%, whereas, it previously closed at $232.17. The company has a market capitalization of $52.82 Billion. The company traded shares of 1.6 Million on the trading day while its three month average volume stands at 1.86 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Autodesk, Inc. (NASDAQ:ADSK) produced diluted EPS of 1.37. The EPS estimate for next year as estimated by analysts is at 5.39 while EPS for next quarter is estimated at 0.9. Earnings per Share growth for this year is reported at 327.8, while the analysts estimated the EPS growth for next year at 5.39% and Earnings growth for next 5 years stands at 32.98% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 23.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Autodesk, Inc. (NASDAQ:ADSK) is at 174.46 while the forward p/e is at 44.42. The P/S or Price to Sales ratio of Autodesk, Inc. (NASDAQ:ADSK) stands at 15.42 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 36.11. The quick ratio and the current ratio of Autodesk, Inc. (NASDAQ:ADSK) are reported at 0.8 and 0.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Autodesk, Inc. (NASDAQ:ADSK) stands at 5.6, -189.6 and 14 respectively

The trailing twelve month Revenue of Autodesk, Inc. (NASDAQ:ADSK) is reported at 3.42 Billion with income of 305.2 Million. The outstanding shares of Autodesk, Inc. (NASDAQ:ADSK) are 219.2 Million. The institutional Ownership of the shares of 96.7 stands at 0.80%, this figure is decreased -0.01 in the last six months. The insider ownership for the shares of Autodesk, Inc. (NASDAQ:ADSK) is ticked at 0.2%, the figure is plummeted -10.25% in the last six months.

Some other important financial aspects to be discussed here for Autodesk, Inc. (NASDAQ:ADSK) is the Mean Target Price estimated by the analysts which stands at 232.14. The 52 week high of Autodesk, Inc. (NASDAQ:ADSK) is placed at 247.14 and 52 week low is standing at 125.38.

Performance wise the shares of Autodesk, Inc. (NASDAQ:ADSK) fell down -1.01% for the week, it also rise 9.07% for the monthly performance, while for the quarter it went down 53.23%. The shares increase 30.49% for the half year and flew up for the Year-To-Date performance. The shares of Autodesk, Inc. (NASDAQ:ADSK) grew 41.29% for the yearly performance.

China Pharma Holdings, Inc. (NYSE:CPHI)

China Pharma Holdings, Inc. (NYSE:CPHI) closed at $0.67 on the last trading session with an decrease of -2.83%, whereas, it previously closed at $0.69. The company has a market capitalization of $31.43 Million. The company traded shares of 2.83 Million on the trading day while its three month average volume stands at 2.05 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of China Pharma Holdings, Inc. (NYSE:CPHI) produced diluted EPS of -0.48. The EPS estimate for next year as estimated by analysts is at 0 while EPS for next quarter is estimated at 0. Earnings per Share growth for this year is reported at -92.6, while the analysts estimated the EPS growth for next year at 0% and Earnings growth for next 5 years stands at 10% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 12.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of China Pharma Holdings, Inc. (NYSE:CPHI) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of China Pharma Holdings, Inc. (NYSE:CPHI) stands at 3.21 and Price to Book or P/B for the most recent quarter stands at 3.51. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of China Pharma Holdings, Inc. (NYSE:CPHI) are reported at 0.2 and 0.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for China Pharma Holdings, Inc. (NYSE:CPHI) stands at -65.7, -113.3 and -149 respectively

The trailing twelve month Revenue of China Pharma Holdings, Inc. (NYSE:CPHI) is reported at 9.8 Million with income of -20900000. The outstanding shares of China Pharma Holdings, Inc. (NYSE:CPHI) are 43.58 Million. The institutional Ownership of the shares of 2.4 stands at 0.80%, this figure is increased 4.43 in the last six months. The insider ownership for the shares of China Pharma Holdings, Inc. (NYSE:CPHI) is ticked at 0.3%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for China Pharma Holdings, Inc. (NYSE:CPHI) is the Mean Target Price estimated by the analysts which stands at 0. The 52 week high of China Pharma Holdings, Inc. (NYSE:CPHI) is placed at 1.40 and 52 week low is standing at 0.21.

Performance wise the shares of China Pharma Holdings, Inc. (NYSE:CPHI) rose up 6.05% for the week, it also rise 49.06% for the monthly performance, while for the quarter it went down 32.23%. The shares increase 186.83% for the half year and flew up for the Year-To-Date performance. The shares of China Pharma Holdings, Inc. (NYSE:CPHI) grew 125.86% for the yearly performance.